ResearcherUniversity of HoustonNo recent work listed

Shivangi Srivastava

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-7971-5804; OpenAlex author ID A5036384221. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2020: 2 papers

Papers 2

Screening of Focused Compound Library Targeting Liver X Receptors in Pancreatic Cancer Identified Ligands with Inverse Agonist and Degrader Activity. Co-author DOI 10.1021/acschembio.0c00546 ↗
Novel Liver X Receptor Ligand GAC0001E5 Disrupts Glutamine Metabolism and Induces Oxidative Stress in Pancreatic Cancer Cells. Co-author DOI 10.3390/ijms21249622 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Chin‐Yo Lin · 2 shared papers, 2020 · strength 0.22
- Paper Novel Liver X Receptor Ligand GAC0001E5 Disrupts Glutamine Metabolism and Induces Oxidative Stress in Pancreatic Cancer… DOI 10.3390/ijms21249622 ↗
- Paper Screening of Focused Compound Library Targeting Liver X Receptors in Pancreatic Cancer Identified Ligands with Inverse … DOI 10.1021/acschembio.0c00546 ↗
Husna Karaboga · 1 shared paper, 2020 · strength 0.10
- Paper Screening of Focused Compound Library Targeting Liver X Receptors in Pancreatic Cancer Identified Ligands with Inverse … DOI 10.1021/acschembio.0c00546 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.